Ligan, Ronelyn L.
HRN: 03-55-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/22/2023
02/28/2023
IV
1.5gram
Q6hrs
Acute Pyelonephritis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes